MedTrace Logo

Alcohol Myopia, Objectification, and Sexual Assault

NCT03956238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 359

Last updated 2023-07-10

No results posted yet for this study

Summary

The present project integrates previous research on factors associated with alcohol-involved sexual assault, with research on how intoxication alters attention and social perceptions in ways that increase the risk of sexual aggression and victimization. Specifically, this project examines whether alcohol intoxication on the part of a male perpetrator impairs attentional capacity and leads to a narrowing of the perceptual field causing a dehumanizing perspective of women as sexual objects for men's pleasure rather than individuals with thoughts and feelings, thereby increasing the propensity for sexual aggression. The present research also examines whether women's responses to this sexual objectification from men interfere with risk perception in sexual situations, particularly when women are drinking, increasing the likelihood of sexual victimization.

Conditions

  • Alcoholic Intoxication

Interventions

BEHAVIORAL

Alcohol intoxication

Men and women assigned to moderate alcohol dose condition (target BAC .08%) or placebo control condition with NIAAA approved alcohol administration procedures

BEHAVIORAL

Objectification

Women assigned to objectifying gazes condition or eye contact control condition

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • University of Nebraska Lincoln

    lead OTHER

Principal Investigators

  • Sarah Gervais, PhD · University of Nebraska Lincoln

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-22
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03956238 on ClinicalTrials.gov